The Justice Department announced today that Assertio Therapeutics Inc., formerly known as Depomed Inc., (Assertio), a pharmaceutical company headquartered in Lake Forest, Illinois, has agreed to pay $3.6 million to resolve claims that Assertio violated the False Claims Act (FCA) by causing the submission of false claims for the transmucosal immediate-release fentanyl (TIRF) Read More
Home » Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Pharmaceutical Manufacturer Assertio Therapeutics Inc. Agrees to Pay
Related Posts
Federal Grand Jury Indicts Essex County, New Jersey Man and Woman for
A federal grand jury in the District of New Jersey, returned an indictment on April 25 that was unsealed Wednesday, charging Treva Edwards, 60, with… BronFederal Grand Jury Indicts Essex County, New Jersey Man and Woman for
Former Colombian Port Official Sentenced to Over Twelve Years in
A Colombian national was sentenced yesterday to 12 years and seven months in prison for conspiring to launder proceeds of bribes. The defendant was also… BronFormer Colombian Port Official Sentenced to Over Twelve Years in
Former D.C.-Area Attorney Charged with Tax Crimes and Making False
An indictment was unsealed charging an attorney with evading taxes on approximately $1 million of income, as well as filing false tax returns and making… BronFormer D.C.-Area Attorney Charged with Tax Crimes and Making False